Insulin-like growth factors in human breast cancer

Neal Rosen, Douglas Yee, Marc E Lippman, Soonmyoung Paik, Kevin J. Cullen

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Several protooncogenes and suppressor genes and a variety of growth factors and their receptors have been shown to be mutated, deleted, or activated in human breast cancer. These changes may account for the unregulated growth of breast carcinoma cells. Insulin-like growth factors I and II (IGF-I, IGF-II) belong to a family of polypeptides with growth promoting properties and structural homology to insulin. They exert their mitogenic effects by binding to the IGF-I receptor and activating its tyrosine protein kinase. Other proteins that specifically bind the IGFs include the plasma membrane IGF-II receptor, which also binds lysosomal hydrolases, and several IGF-binding proteins which may serve to modulate IGF interactions with receptors. Breast cancer cell lines express IGF-I and IGF-II receptors and different patterns of binding proteins. IGF-I and IGF-II are each mitogenic for subsets of breast cancer cell lines. This effect is inhibited by antibodies directed against the IGF-I receptor. In breast tumors, IGF-I is expressed by stromal cells, but not carcinoma cells; it is not expressed by breast cancer cell lines. IGF-I is therefore a potential paracrine regulator of breast cancer cell growth. Similarly, IGF-II is expressed in breast tumors, predominantly in stromal cells, but sometimes also in carcinoma cells and in a subset of cell lines. Thus, IGF-II is also a potential paracrine regulator of breast cancer cell growth; in addition, it can be an autocrine regulator in some breast cancer cells.

Original languageEnglish
JournalBreast Cancer Research and Treatment
Volume18
Issue number1 Supplement
DOIs
StatePublished - May 1 1991
Externally publishedYes

Fingerprint

Somatomedins
Breast Neoplasms
Insulin-Like Growth Factor II
Insulin-Like Growth Factor I
IGF Type 2 Receptor
Cell Line
IGF Type 1 Receptor
Stromal Cells
Growth
Suppressor Genes
Carcinoma
Insulin-Like Growth Factor Binding Proteins
Growth Factor Receptors
Hydrolases
Protein-Tyrosine Kinases
Carrier Proteins
Cell Membrane
Insulin
Peptides
Antibodies

Keywords

  • breast cancer
  • growth factors
  • insulin-like growth factors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Rosen, N., Yee, D., Lippman, M. E., Paik, S., & Cullen, K. J. (1991). Insulin-like growth factors in human breast cancer. Breast Cancer Research and Treatment, 18(1 Supplement). https://doi.org/10.1007/BF02633529

Insulin-like growth factors in human breast cancer. / Rosen, Neal; Yee, Douglas; Lippman, Marc E; Paik, Soonmyoung; Cullen, Kevin J.

In: Breast Cancer Research and Treatment, Vol. 18, No. 1 Supplement, 01.05.1991.

Research output: Contribution to journalArticle

Rosen, N, Yee, D, Lippman, ME, Paik, S & Cullen, KJ 1991, 'Insulin-like growth factors in human breast cancer', Breast Cancer Research and Treatment, vol. 18, no. 1 Supplement. https://doi.org/10.1007/BF02633529
Rosen N, Yee D, Lippman ME, Paik S, Cullen KJ. Insulin-like growth factors in human breast cancer. Breast Cancer Research and Treatment. 1991 May 1;18(1 Supplement). https://doi.org/10.1007/BF02633529
Rosen, Neal ; Yee, Douglas ; Lippman, Marc E ; Paik, Soonmyoung ; Cullen, Kevin J. / Insulin-like growth factors in human breast cancer. In: Breast Cancer Research and Treatment. 1991 ; Vol. 18, No. 1 Supplement.
@article{9cf7392ffed946a8908124f2bae46422,
title = "Insulin-like growth factors in human breast cancer",
abstract = "Several protooncogenes and suppressor genes and a variety of growth factors and their receptors have been shown to be mutated, deleted, or activated in human breast cancer. These changes may account for the unregulated growth of breast carcinoma cells. Insulin-like growth factors I and II (IGF-I, IGF-II) belong to a family of polypeptides with growth promoting properties and structural homology to insulin. They exert their mitogenic effects by binding to the IGF-I receptor and activating its tyrosine protein kinase. Other proteins that specifically bind the IGFs include the plasma membrane IGF-II receptor, which also binds lysosomal hydrolases, and several IGF-binding proteins which may serve to modulate IGF interactions with receptors. Breast cancer cell lines express IGF-I and IGF-II receptors and different patterns of binding proteins. IGF-I and IGF-II are each mitogenic for subsets of breast cancer cell lines. This effect is inhibited by antibodies directed against the IGF-I receptor. In breast tumors, IGF-I is expressed by stromal cells, but not carcinoma cells; it is not expressed by breast cancer cell lines. IGF-I is therefore a potential paracrine regulator of breast cancer cell growth. Similarly, IGF-II is expressed in breast tumors, predominantly in stromal cells, but sometimes also in carcinoma cells and in a subset of cell lines. Thus, IGF-II is also a potential paracrine regulator of breast cancer cell growth; in addition, it can be an autocrine regulator in some breast cancer cells.",
keywords = "breast cancer, growth factors, insulin-like growth factors",
author = "Neal Rosen and Douglas Yee and Lippman, {Marc E} and Soonmyoung Paik and Cullen, {Kevin J.}",
year = "1991",
month = "5",
day = "1",
doi = "10.1007/BF02633529",
language = "English",
volume = "18",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1 Supplement",

}

TY - JOUR

T1 - Insulin-like growth factors in human breast cancer

AU - Rosen, Neal

AU - Yee, Douglas

AU - Lippman, Marc E

AU - Paik, Soonmyoung

AU - Cullen, Kevin J.

PY - 1991/5/1

Y1 - 1991/5/1

N2 - Several protooncogenes and suppressor genes and a variety of growth factors and their receptors have been shown to be mutated, deleted, or activated in human breast cancer. These changes may account for the unregulated growth of breast carcinoma cells. Insulin-like growth factors I and II (IGF-I, IGF-II) belong to a family of polypeptides with growth promoting properties and structural homology to insulin. They exert their mitogenic effects by binding to the IGF-I receptor and activating its tyrosine protein kinase. Other proteins that specifically bind the IGFs include the plasma membrane IGF-II receptor, which also binds lysosomal hydrolases, and several IGF-binding proteins which may serve to modulate IGF interactions with receptors. Breast cancer cell lines express IGF-I and IGF-II receptors and different patterns of binding proteins. IGF-I and IGF-II are each mitogenic for subsets of breast cancer cell lines. This effect is inhibited by antibodies directed against the IGF-I receptor. In breast tumors, IGF-I is expressed by stromal cells, but not carcinoma cells; it is not expressed by breast cancer cell lines. IGF-I is therefore a potential paracrine regulator of breast cancer cell growth. Similarly, IGF-II is expressed in breast tumors, predominantly in stromal cells, but sometimes also in carcinoma cells and in a subset of cell lines. Thus, IGF-II is also a potential paracrine regulator of breast cancer cell growth; in addition, it can be an autocrine regulator in some breast cancer cells.

AB - Several protooncogenes and suppressor genes and a variety of growth factors and their receptors have been shown to be mutated, deleted, or activated in human breast cancer. These changes may account for the unregulated growth of breast carcinoma cells. Insulin-like growth factors I and II (IGF-I, IGF-II) belong to a family of polypeptides with growth promoting properties and structural homology to insulin. They exert their mitogenic effects by binding to the IGF-I receptor and activating its tyrosine protein kinase. Other proteins that specifically bind the IGFs include the plasma membrane IGF-II receptor, which also binds lysosomal hydrolases, and several IGF-binding proteins which may serve to modulate IGF interactions with receptors. Breast cancer cell lines express IGF-I and IGF-II receptors and different patterns of binding proteins. IGF-I and IGF-II are each mitogenic for subsets of breast cancer cell lines. This effect is inhibited by antibodies directed against the IGF-I receptor. In breast tumors, IGF-I is expressed by stromal cells, but not carcinoma cells; it is not expressed by breast cancer cell lines. IGF-I is therefore a potential paracrine regulator of breast cancer cell growth. Similarly, IGF-II is expressed in breast tumors, predominantly in stromal cells, but sometimes also in carcinoma cells and in a subset of cell lines. Thus, IGF-II is also a potential paracrine regulator of breast cancer cell growth; in addition, it can be an autocrine regulator in some breast cancer cells.

KW - breast cancer

KW - growth factors

KW - insulin-like growth factors

UR - http://www.scopus.com/inward/record.url?scp=0026165611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026165611&partnerID=8YFLogxK

U2 - 10.1007/BF02633529

DO - 10.1007/BF02633529

M3 - Article

VL - 18

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1 Supplement

ER -